Filing Details
- Accession Number:
- 0001387131-16-005280
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-05 17:18:45
- Reporting Period:
- 2016-05-03
- Filing Date:
- 2016-05-05
- Accepted Time:
- 2016-05-05 17:18:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887247 | Adamis Pharmaceuticals Corp | ADMP | Pharmaceutical Preparations (2834) | 820429727 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1461753 | J. David Marguglio | C/O Adamis Pharmaceuticals Corporation 11682 El Camino Real, Suite 300 San Diego, CA 92130 | Sr Vp Of Corporate Development | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-05-03 | 1,140 | $9.00 | 117,087 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted in September 2015.